The use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinoma

BACKGROUND: The role of fulvestrant in the management of intestinal obstruction associated with lobular carcinoma has not been specifically described. CASE PRESENTATION: Herein we present two cases where fulvestrant, as the only available parenteral endocrine agent for postmenopausal advanced breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Jasmine YM, Rampaul, Rajendra Singh, Cheung, Kwok L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613396/
https://www.ncbi.nlm.nih.gov/pubmed/19046426
http://dx.doi.org/10.1186/1477-7819-6-128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613396/
https://www.ncbi.nlm.nih.gov/pubmed/19046426
http://dx.doi.org/10.1186/1477-7819-6-128

Ejemplares similares